ヌクレオチド市場レポート：タイプ別、技術別、形態別、用途別、地域別、2025-2033年

ヌクレオチド市場の世界市場規模は2024年に7億6,270万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに12億8,830万米ドルに達し、2025年から2033年の間に6％の成長率（CAGR）を示すと予測しています。乳児栄養の需要の高まりと動物飼料の使用の増加が市場を刺激しています。

ヌクレオチドは、リボ核酸（RNA）やデオキシリボ核酸（DNA）などの核酸の基本構成要素です。様々な代謝プロセスや、細胞内で合成されるタンパク質の構造形成を促進します。酵素とともに作用し、体内の生化学反応を促進します。また、プリン作動性受容体との相互作用を通じて、高分子の生合成や細胞シグナル伝達を助ける。さらに、ヌクレオチドは体内で遺伝情報のコード化、伝達、発現を助ける。ヌクレオチドは、ヘルペスウイルス群に対して高い効力と選択性を示すことから、抗ウイルス剤や抗がん剤として多くの医薬品に使用されています。

ヌクレオチド市場動向：

現在、世界中でヨーグルトや練乳、粉ミルクなどの乳製品におけるヌクレオチドサプリメントの利用が増加しています。これは、粉末液の形でこれらのサプリメントを利用できるようになりつつあることと共に、市場を牽引する重要な要因の一つとなっています。これに加えて、栄養不良、ストレス、高血圧などの症状を治療するための栄養補助食品におけるヌクレオチドの採用が増加していることも、市場の成長に寄与しています。さらに、様々なウイルス性疾患やがんの種類を診断するための診断研究において、ヌクレオチドの応用が増加していることが、市場の成長を促進しています。さらに、家畜の代謝率を維持するための動物飼料におけるヌクレオチドの需要が増加しています。これは、動物の病気の有害な影響に関する大衆の意識の高まりと相まって、市場にプラスの影響を与えています。これとは別に、免疫システムを強化するのに役立つ腸管上皮細胞の回復を強化するためのヌクレオチドに対する需要の高まりは、市場の見通しをポジティブなものにしています。さらに、乳児用食品製剤におけるリボヌクレオチドの使用量の増加が、市場の成長を後押ししています。

本レポートで扱う主な質問

• 世界のヌクレオチド市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
• COVID-19が世界のヌクレオチド市場に与えた影響は？
• 主要地域市場とは？
• タイプ別の市場内訳は？
• 技術別の市場内訳は？
• 形態別の市場内訳は？
• 用途別の市場内訳は？
• 業界のバリューチェーンにおける様々な段階とは？
• 業界の主要な促進要因と課題は何か？
• 世界のヌクレオチド市場の構造と主要プレーヤーは？
• 業界の競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要業界動向

第5章 世界のヌクレオチド市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場予測

第6章 市場内訳：タイプ別

• 食品グレード
  • 市場動向
  • 市場予測
• 研究グレード
  • 市場動向
  • 市場予測
• 産業グレード
  • 市場動向
  • 市場予測
• その他
  • 市場動向
  • 市場予測

第7章 市場内訳：技術別

• TaqMan対立遺伝子識別
  • 市場動向
  • 市場予測
• 遺伝子チップとマイクロアレイ
  • 市場動向
  • 市場予測
• パイロシークエンス法によるSNP
  • 市場動向
  • 市場予測
• その他
  • 市場動向
  • 市場予測

第8章 市場内訳：形態別

• 液体
  • 市場動向
  • 市場予測
• 粉末
  • 市場動向
  • 市場予測

第9章 市場内訳：用途別

• 製薬
  • 市場動向
  • 市場予測
• 食品および動物飼料添加物
  • 市場動向
  • 市場予測
• 創薬
  • 市場動向
  • 市場予測
• その他
  • 市場動向
  • 市場予測

第10章 市場内訳：地域別

• 北米
  • 米国
  • カナダ
• アジア太平洋地域
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
• 中東・アフリカ

第11章 SWOT分析

• 概要
• 強み
• 弱み
• 機会
• 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第14章 価格分析

第15章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • CJ CheilJedang Corporation
  • Exotic Biosolutions
  • F. Hoffmann-La Roche AG
  • Jena Bioscience GmbH
  • Koninklijke DSM N.V.
  • Lallemand Inc.
  • Meridian Bioscience Inc.
  • Nanjing Biotogether Co. Ltd.
  • Ohly GmbH（Associated British Foods plc）
  • Promega Corporation
  • Starlake Bioscience Co. Inc.
  • Thermo Fisher Scientific Inc.

List of Figures

• Figure 1: Global: Nucleotides Market: Major Drivers and Challenges
• Figure 2: Global: Nucleotides Market: Sales Value (in Million USD), 2019-2024
• Figure 3: Global: Nucleotides Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 4: Global: Nucleotides Market: Breakup by Type (in %), 2024
• Figure 5: Global: Nucleotides Market: Breakup by Technology (in %), 2024
• Figure 6: Global: Nucleotides Market: Breakup by Form (in %), 2024
• Figure 7: Global: Nucleotides Market: Breakup by Application (in %), 2024
• Figure 8: Global: Nucleotides Market: Breakup by Region (in %), 2024
• Figure 9: Global: Nucleotides (Food Grade) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 10: Global: Nucleotides (Food Grade) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 11: Global: Nucleotides (Lab Grade) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 12: Global: Nucleotides (Lab Grade) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 13: Global: Nucleotides (Industry Grade) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 14: Global: Nucleotides (Industry Grade) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 15: Global: Nucleotides (Other Types) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 16: Global: Nucleotides (Other Types) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 17: Global: Nucleotides (TaqMan Allelic Discrimination) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 18: Global: Nucleotides (TaqMan Allelic Discrimination) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 19: Global: Nucleotides (Gene Chips and Microarrays) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 20: Global: Nucleotides (Gene Chips and Microarrays) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 21: Global: Nucleotides (SNP by Pyrosequencing) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 22: Global: Nucleotides (SNP by Pyrosequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 23: Global: Nucleotides (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 24: Global: Nucleotides (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 25: Global: Nucleotides (Liquid) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 26: Global: Nucleotides (Liquid) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 27: Global: Nucleotides (Powder) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 28: Global: Nucleotides (Powder) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 29: Global: Nucleotides (Pharmaceutical) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 30: Global: Nucleotides (Pharmaceutical) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 31: Global: Nucleotides (Food and Animal Feed Additives) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 32: Global: Nucleotides (Food and Animal Feed Additives) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 33: Global: Nucleotides (Drug Discovery) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 34: Global: Nucleotides (Drug Discovery) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 35: Global: Nucleotides (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 36: Global: Nucleotides (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 37: North America: Nucleotides Market: Sales Value (in Million USD), 2019 & 2024
• Figure 38: North America: Nucleotides Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 39: United States: Nucleotides Market: Sales Value (in Million USD), 2019 & 2024
• Figure 40: United States: Nucleotides Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 41: Canada: Nucleotides Market: Sales Value (in Million USD), 2019 & 2024
• Figure 42: Canada: Nucleotides Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 43: Asia-Pacific: Nucleotides Market: Sales Value (in Million USD), 2019 & 2024
• Figure 44: Asia-Pacific: Nucleotides Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 45: China: Nucleotides Market: Sales Value (in Million USD), 2019 & 2024
• Figure 46: China: Nucleotides Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 47: Japan: Nucleotides Market: Sales Value (in Million USD), 2019 & 2024
• Figure 48: Japan: Nucleotides Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 49: India: Nucleotides Market: Sales Value (in Million USD), 2019 & 2024
• Figure 50: India: Nucleotides Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 51: South Korea: Nucleotides Market: Sales Value (in Million USD), 2019 & 2024
• Figure 52: South Korea: Nucleotides Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 53: Australia: Nucleotides Market: Sales Value (in Million USD), 2019 & 2024
• Figure 54: Australia: Nucleotides Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 55: Indonesia: Nucleotides Market: Sales Value (in Million USD), 2019 & 2024
• Figure 56: Indonesia: Nucleotides Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 57: Others: Nucleotides Market: Sales Value (in Million USD), 2019 & 2024
• Figure 58: Others: Nucleotides Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 59: Europe: Nucleotides Market: Sales Value (in Million USD), 2019 & 2024
• Figure 60: Europe: Nucleotides Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 61: Germany: Nucleotides Market: Sales Value (in Million USD), 2019 & 2024
• Figure 62: Germany: Nucleotides Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 63: France: Nucleotides Market: Sales Value (in Million USD), 2019 & 2024
• Figure 64: France: Nucleotides Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 65: United Kingdom: Nucleotides Market: Sales Value (in Million USD), 2019 & 2024
• Figure 66: United Kingdom: Nucleotides Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 67: Italy: Nucleotides Market: Sales Value (in Million USD), 2019 & 2024
• Figure 68: Italy: Nucleotides Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 69: Spain: Nucleotides Market: Sales Value (in Million USD), 2019 & 2024
• Figure 70: Spain: Nucleotides Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 71: Russia: Nucleotides Market: Sales Value (in Million USD), 2019 & 2024
• Figure 72: Russia: Nucleotides Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 73: Others: Nucleotides Market: Sales Value (in Million USD), 2019 & 2024
• Figure 74: Others: Nucleotides Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 75: Latin America: Nucleotides Market: Sales Value (in Million USD), 2019 & 2024
• Figure 76: Latin America: Nucleotides Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 77: Brazil: Nucleotides Market: Sales Value (in Million USD), 2019 & 2024
• Figure 78: Brazil: Nucleotides Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 79: Mexico: Nucleotides Market: Sales Value (in Million USD), 2019 & 2024
• Figure 80: Mexico: Nucleotides Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 81: Others: Nucleotides Market: Sales Value (in Million USD), 2019 & 2024
• Figure 82: Others: Nucleotides Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 83: Middle East and Africa: Nucleotides Market: Sales Value (in Million USD), 2019 & 2024
• Figure 84: Middle East and Africa: Nucleotides Market: Breakup by Country (in %), 2024
• Figure 85: Middle East and Africa: Nucleotides Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 86: Global: Nucleotides Industry: SWOT Analysis
• Figure 87: Global: Nucleotides Industry: Value Chain Analysis
• Figure 88: Global: Nucleotides Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Nucleotides Market: Key Industry Highlights, 2024 & 2033
• Table 2: Global: Nucleotides Market Forecast: Breakup by Type (in Million USD), 2025-2033
• Table 3: Global: Nucleotides Market Forecast: Breakup by Technology (in Million USD), 2025-2033
• Table 4: Global: Nucleotides Market Forecast: Breakup by Form (in Million USD), 2025-2033
• Table 5: Global: Nucleotides Market Forecast: Breakup by Application (in Million USD), 2025-2033
• Table 6: Global: Nucleotides Market Forecast: Breakup by Region (in Million USD), 2025-2033
• Table 7: Global: Nucleotides Market: Competitive Structure
• Table 8: Global: Nucleotides Market: Key Players

The global nucleotides market size reached USD 762.7 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,288.3 Million by 2033, exhibiting a growth rate (CAGR) of 6% during 2025-2033. The rising demand for infant nutrition and the increasing use of animal feed are stimulating the market.

Nucleotides are the basic building block of nucleic acids, such as ribonucleic acid (RNA) and deoxyribonucleic acid (DNA). They enhance various metabolic processes and the formation of the structure of proteins synthesized in the cell. They act with enzymes to speed up biochemical reactions in the body. They also aid in the biosynthesis of macromolecules and cell signaling through interaction with purinergic receptors. In addition, nucleotides assist in encoding, transmitting, and expressing genetic information in the body. As they provide a high degree of potency and selectivity against the herpes group of viruses, nucleotides are used as antiviral or anticancer agents in several medicines.

Nucleotides Market Trends:

At present, there is a rise in the utilization of nucleotide supplements in dairy products, such as yogurt and condensed and powdered milk, across the globe. This, along with the growing availability of these supplements in the form of powdered fluids, represents one of the key factors driving the market. Besides this, the increasing employment of nucleotides in nutraceuticals to treat conditions, such as poor nutrition, stress, and hypertension, is contributing to the growth of the market. In addition, the rising application of nucleotides in diagnostic research to diagnose the presence of various viral diseases and types of cancer is propelling the growth of the market. Moreover, there is an increase in the demand for nucleotides in animal feed to maintain metabolism rates in livestock. This, coupled with the growing awareness among the masses about the harmful impacts of animal diseases, is positively influencing the market. Apart from this, the escalating demand for nucleotides to enhance the recovery of intestinal epithelial cells, which helps boost the immunity system, is offering a positive market outlook. Additionally, the increasing usage of ribonucleotides in infant food formulations is bolstering the growth of the market.

Key Market Segmentation:

Breakup by Type:

Food Grade

Lab Grade

Industry Grade

Others

Breakup by Technology:

TaqMan Allelic Discrimination

Gene Chips and Microarrays

SNP by Pyrosequencing

Others

Breakup by Form:

Liquid

Powder

Breakup by Application:

Pharmaceutical

Food and Animal Feed Additives

Drug Discovery

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being CJ CheilJedang Corporation, Exotic Biosolutions, F. Hoffmann-La Roche AG, Jena Bioscience GmbH, Koninklijke DSM N.V., Lallemand Inc., Meridian Bioscience Inc., Nanjing Biotogether Co. Ltd., Ohly GmbH (Associated British Foods plc), Promega Corporation, Starlake Bioscience Co. Inc. and Thermo Fisher Scientific Inc. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

• How has the global nucleotides market performed so far, and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global nucleotides market?
• What are the key regional markets?
• What is the breakup of the market based on the type?
• What is the breakup of the market based on the technology?
• What is the breakup of the market based on the form?
• What is the breakup of the market based on the application?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global nucleotides market, and who are the key players?
• What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Nucleotides Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Food Grade
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Lab Grade
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Industry Grade
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Others
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast

7 Market Breakup by Technology

• 7.1 TaqMan Allelic Discrimination
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Gene Chips and Microarrays
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 SNP by Pyrosequencing
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Others
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by Form

• 8.1 Liquid
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Powder
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast

9 Market Breakup by Application

• 9.1 Pharmaceutical
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Food and Animal Feed Additives
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Drug Discovery
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Others
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 CJ CheilJedang Corporation
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
    • 15.3.1.3 Financials
  • 15.3.2 Exotic Biosolutions
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
  • 15.3.3 F. Hoffmann-La Roche AG
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
    • 15.3.3.3 Financials
  • 15.3.4 Jena Bioscience GmbH
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
  • 15.3.5 Koninklijke DSM N.V.
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
    • 15.3.5.3 Financials
    • 15.3.5.4 SWOT Analysis
  • 15.3.6 Lallemand Inc.
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
  • 15.3.7 Meridian Bioscience Inc.
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
    • 15.3.7.3 Financials
    • 15.3.7.4 SWOT Analysis
  • 15.3.8 Nanjing Biotogether Co. Ltd.
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
  • 15.3.9 Ohly GmbH (Associated British Foods plc)
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
  • 15.3.10 Promega Corporation
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
  • 15.3.11 Starlake Bioscience Co. Inc.
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio
    • 15.3.11.3 Financials
  • 15.3.12 Thermo Fisher Scientific Inc.
    • 15.3.12.1 Company Overview
    • 15.3.12.2 Product Portfolio
    • 15.3.12.3 Financials
    • 15.3.12.4 SWOT Analysis

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report